Wet AMD 5 Symposium

Related

• 

  Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD

  Peter A. Campochiaro, MD

  Updates from the Field

  2020

• 

  Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study

  Carl J Danzig, MD

  Updates from the Field

  2022

• 

  Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial

  Peter A. Campochiaro, MD

  Updates from the Field

  2021